BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. Their technology platform uniquely positions them to rapidly and cost-effectively discover new high-value biomarkers over a broad range of therapeutic categories that promise to be highly correlated to clinical outcomes. The company has R&D partnerships with leading pharmaceutical companies that to date include AstraZeneca, GlaxoSmithKline, Pfizer, Merck, Novartis, Abbott, Takeda, Eisai, Johnson & Johnson, and Mitsubishi, as well as managed care company Humana.

Flagship Managing Partner Noubar Afeyan is a founder and Executive Chairman of the Board of Directors.

www.bg-medicine.com